ABSTRACT
Screening
of kunun-zaki samples for Methicillin Resistant Staphylococcus aureus,
Vancomycin Resistant Staphylococcus aureus and Extended Spectrum Beta Lactamase
producing Salmonella was investigated. A total of 40 samples were collected and
a total of 19 Salmonella and 22 Staphylococcus aureus were isolated. The total
Salmonella count ranged from 3.4xl05to 1.90 x 106with a mean of 14.2 x 105
while the S.aureus count ranged from 3.4 x 105to 1.58 x 105 with a mean of
184.5 x 105. All the isolated organisms were subjected to in-vitro antibiotic
susceptibility test using Kirby Bauer disc diffusion method. A total of 14
antibiotic discs namely Ceftazidime (CAZ 30pg), Cefuroxime (CRX 30pg),
Gentamicin (GEN lOpg), Ciprofloxacin (CPR 5 pg), Ofloxacin (OFL 5pg),
Augumentin (AUG 30pg), Nitrofurantoin (NIT 300pg), Ampicillin (AMP lOpg), Imipenem
(IMP 1 Opg), Erythromycin (E 30pg), Meropenem (MER lOpg), Vancomycin (VAN
lOpg), Cloxicillin (CXC 5pg), and Oxacillin (OX 10 pg) were used. Most of the
Salmonella isolates were susceptible toCeftazidime (94.7%) followed by
Ofloxacin (89.5%) while they exhibited resistance to Meropenem (73.7%) and
Imipenem (57.9%). Also the Salmonella isolates were screened for ESBL
production in accordance to the CLSI breakpoint and 12(63.2) were positive. On
subjection of the 12 isolates to double disc synergy test (DDST), 5 (41.7%)
were confirmed to be ESBL producers. A good number oftheS.aureus isolates were
susceptible to Ofloxacin (95.5%) followed by Augumentin (72.7%) and when
subjected to MRSA testing using Oxacillin, 9(40.9%) were resistant while
10(45.5%) and 3(13.6%) exhibited intermediate and susceptible results to
Oxacillin respectively. VRSA were also confirmed when the isolates were
subjected to Vancomycin antibiotic and 5(22.7%) isolates were resistant while
15(68.2%) and 2(9.1%) had intermediate and susceptible results respectively.
DANIEL, K (2024). Screening Of Kunun-Zaki For Methicillin Resistant Staphylococcus aureus, Vancomycin Resistant Staphylococcus aureus and Extended Spectrum Beta Lactamase Producing Salmonella:- Emeaso, Daniel K. Mouau.afribary.org: Retrieved Sep 08, 2024, from https://repository.mouau.edu.ng/work/view/screening-of-kunun-zaki-for-methicillin-resistant-staphylococcus-aureus-vancomycin-resistant-staphylococcus-aureus-and-extended-spectrum-beta-lactamase-producing-salmonella-emeaso-daniel-k-7-2
KELECHI, DANIEL. "Screening Of Kunun-Zaki For Methicillin Resistant Staphylococcus aureus, Vancomycin Resistant Staphylococcus aureus and Extended Spectrum Beta Lactamase Producing Salmonella:- Emeaso, Daniel K" Mouau.afribary.org. Mouau.afribary.org, 25 Jun. 2024, https://repository.mouau.edu.ng/work/view/screening-of-kunun-zaki-for-methicillin-resistant-staphylococcus-aureus-vancomycin-resistant-staphylococcus-aureus-and-extended-spectrum-beta-lactamase-producing-salmonella-emeaso-daniel-k-7-2. Accessed 08 Sep. 2024.
KELECHI, DANIEL. "Screening Of Kunun-Zaki For Methicillin Resistant Staphylococcus aureus, Vancomycin Resistant Staphylococcus aureus and Extended Spectrum Beta Lactamase Producing Salmonella:- Emeaso, Daniel K". Mouau.afribary.org, Mouau.afribary.org, 25 Jun. 2024. Web. 08 Sep. 2024. < https://repository.mouau.edu.ng/work/view/screening-of-kunun-zaki-for-methicillin-resistant-staphylococcus-aureus-vancomycin-resistant-staphylococcus-aureus-and-extended-spectrum-beta-lactamase-producing-salmonella-emeaso-daniel-k-7-2 >.
KELECHI, DANIEL. "Screening Of Kunun-Zaki For Methicillin Resistant Staphylococcus aureus, Vancomycin Resistant Staphylococcus aureus and Extended Spectrum Beta Lactamase Producing Salmonella:- Emeaso, Daniel K" Mouau.afribary.org (2024). Accessed 08 Sep. 2024. https://repository.mouau.edu.ng/work/view/screening-of-kunun-zaki-for-methicillin-resistant-staphylococcus-aureus-vancomycin-resistant-staphylococcus-aureus-and-extended-spectrum-beta-lactamase-producing-salmonella-emeaso-daniel-k-7-2